openPR Logo
Press release

Liquid Biopsy Market Liquid Biopsy Technology Sales Report 2020

07-11-2017 12:24 PM CET | Health & Medicine

Press release from: Kuick Resarch

Liquid Biopsy Market Liquid Biopsy Technology Sales Report 2020

For Report Sample Contact: or +91-11-47067990

Report Table of Contents

1. Introduction to Liquid Biopsy: A Non-Invasive, Game-Changer Diagnostic Tool

2. Mechanism of Action: Major Components of Liquid Biopsy
2.1 Circulating Tumor Cells
2.1.1 Parameters Guiding Circulating Cell Tumors
2.2 Circulating Tumor Nucleic Acids (ctNA)
2.2.1 Cell-Free Tumor DNA
2.2.2 Other Circulatory Tumor Nucleic Acid: microRNA, mRNA & Long Non-Coding RNAs
2.3 Exosomes

3. Circulatory Tumor Cells: A Snapshot; Its History, Biologics, Selection Method, Detection Procedures, Enrichment Procedures, Analysis & Disease Monitoring
3.1 The History & Introduction
3.2 The Selection Methods
3.3 The Analysis Methodologies
3.4 The Scope of Disease Monitoring
3.5 The Biologics of Circulatory Tumor Cells

4. Diagnostic Technological Advancement Supplementing Liquid Biopsy Market
4.1 Glimpses to the Next Generation Sequencing Techniques
4.2 Methodologies Involved in the Next Generation Sequencing
4.2.1 Genomics
4.2.2 Transcriptomics
4.2.3 Epigenomics
4.3 Flowchart Depicting Genomic Analysis Using Next Generation Sequencing
4.3.1 A Basic Workflow of Next Generation Sequencers
4.3.2 Integrated Data Analysis
4.4 Pricing Implications of Next Generation Sequencing On the Liquid Biopsy Market

5. Clinical Investigation Using Cell-Free Circulating Tumor DNA for Different Indications
5.1 Lung Cancer
5.2 Breast Cancer
5.3 Colorectal Cancer
5.4 Melanoma
5.5 Gastric Cancer
5.6 Prostate Cancer
5.7 Brain Cancer
5.8 Detection & Monitoring of Type 1 Diabetes
5.9 Pancreatic Cancer
5.10 Renal Cancer
5.11 Retinoblastoma

6. Combinational Analysis on the Working of Circulating Tumor Cells & Cell-Free Tumor DNA

7. Business Model of Liquid Biopsy Market: A Hotbed for Start-Ups and Venture Capital Funding

8. Other Market Modalities Associated With Liquid Biopsy
8.1 Accreditation through Clinical Laboratory Improvement Amendments (CLIA) Testing: Green Signal for Liquid Biopsy
8.2 The Impact of Service Providers in Liquid Biopsy Market
8.3 The Role of Liquid Biopsy In The Light Of Insurance Associated Issues

9. Liquid Biopsy Market Share in North America, Europe, Asia- Pacific & Rest of the World
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
9.4.1 Africa
9.4.2 South America
9.4.3 Middle East

10. Market Drivers: Clinical Utilities of Liquid Biopsy. Why Do We Need Them?
10.1 Help Monitor Minimal Residue Disease
10.2 Help Track Emergence of Drug Resistance
10.3 Liquid Biopsy Used As a Predictive & Pharmacodynamic Biomarker
10.3.1 Cell-Free Tumor DNA as Predictive Biomarker
10.3.2 Cell-Free Tumor DNA as Pharmacodynamic Biomarker

11. Market Trends in Liquid Biopsy. Is The Era Of Tissue Biopsy Coming To An End?

12. Market Share of Different Liquid Biopsy Techniques

13. Market Challenges: Liquid biopsy, A Revolution in Cancer Diagnosis; a Myth or a Reality?
13.1 Complex Immuno-Biochemical Mechanism of Cancer Cells
13.2 The Risk of False Positive Liquid Biopsy Test
13.3 The Risk of False Negative Liquid Biopsy Test
13.4 Inconclusive Nature of Cancer Biomarkers
13.5 Lack of Standardized Protocols
13.6 Business Model Based Challenges
13.7 Issues Related To Regulatory Framework

14. Conclusion: Liquid Biopsy; Real-Time & Revolutionary Novel Diagnostic Tool

15. Competitive Landscape
15.1 AdnaGen (QIAGEN)
15.2 Agena Bioscience
15.3 Angle
15.4 ApoCell
15.5 Biocept
15.6 BioFluidica
15.7 Bio-Rad Laboratories
15.8 Boreal Genomics
15.9 Chronix Biomedical
15.10 Clearbridge BioMedics
15.11 Cynvenio
15.12 Cytotrack
15.13 Epic Sciences
15.14 Exosome Diagnostics
15.15 Fluidigm
15.16 Fluxion Biosciences
15.17 Genomic Health
15.18 Guardant Health
15.19 HansaBiomed
15.20 Horizon Discovery
15.21 iCellate
15.22 Illumina
15.23 Inivata
15.24 Janssen Diagnostics
15.25 Molecular MD
15.26 Myriad Genetics
15.27 Natera

Download Report:

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liquid Biopsy Market Liquid Biopsy Technology Sales Report 2020 here

News-ID: 619046 • Views: 240

More Releases from Kuick Resarch

Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024
"Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024" Report Highlights: • Commutative Market Opportunity During Initial 5 years of Commercialization: > US$ 2 Billion • Trispecific Antibodies In Clinical Trials: > 8 Antibodies • Highest Phase of Development: Phase I/II • Cancer Dominating Trispecific Antibodies Trials: > 5 Antibodies • Numab Therapeutics Dominating the Trispecific Development Pipeline • Prevention & Second Line Therapy Key Focus of Development of Trispecific Antibodies Download Report: Trispecific cancer antibody therapy market at
Global BiTE Antibodies Market, Price, Sales & Clinical Trials Insight 2025
"Global BiTE Antibodies Market, Price, Sales & Clinical Trials Insight 2025" Report Highlights: • Global BiTE Antibody Market Opportunity Insight (2021-2025) • Currently Only 1 BiTE Commercially Available In Market: Blinatumomab (Blincyto) • Blincyto Dosage & Market Sales Analysis ( Yearly, Quarterly & Regional Sales) • Global BiTE Antibody Clinical Trials Indicators by Phase, Company, Country, Indication & Patient Segment • Global Bispecific T-Cell Engagers Market Dynamics Download Report: The research report, "Global BiTE Antibodies Market , Price, Sales &
Global BCL-2 (B Cell Lymphoma 2) Inhibitors Market & Clinical Trials Insight 202 …
"Global BCL-2 (B Cell Lymphoma 2) Inhibitors Market & Clinical Trials Insight 2025" Report Highlights: • Global BCL-2 Inhibitors Market Opportunity: >US$ 4 Billion by 2025 • Insight on Market Indicators & Approved Drugs Sales Data • Global BCL-2 Inhibitors Market Absolute Growth: >300% ( 97% CAGR, 2018 - 2020) • Comprehensive Information On Ongoing Clinical Trials • Global BCL-2 inhibitors Clinical Trials By Company, Indication & Phase • Venetoclax Is The First Approved Drug Belonging To The Class Of BCL2
Global Antibody Drug Conjugate Market Sales Size Opportunity To Surpass US$ 10 B …
"Novel Cancer Antibody Drug Conjugates to Drive Cancer Therapeutics Market With More Than 290 Cancer Antibodies In Clinical Trials Pipeline Says Kuick Research" "Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Antibody Drug Conjugate (ADC) Pipeline: 297 Drugs • Marketed Cancer Antibody Drug Conjugate: 9 Drugs • Antibody Drug Conjugate Marketed Opportunity: > US$ 13 Billion By 2026 • Majority of Drug Trials Are For Second Line Therapy

All 5 Releases

More Releases for Liquid

Liquid Biopsy Market
Liquid biopsies are non-invasive blood tests that detect tumor DNA & RNA fragments and circulating tumor cells (CTCs), which are released into the blood from the primary tumors and metastatic sites. It is a minimally invasive technology for the detection of molecular biomarkers, excluding expensive or invasive procedures. The global liquid biopsy market accounted for $634 million in 2016, and is estimated to reach
Liquid Applied Membranes Market 2025 |
Liquid Applied Membrane (LAM) is a lowly thickness waterproofing film that is employed in the form of a liquid covering to vertical along with horizontal surfaces. The LAM is, in addition, believed as a cutting-edge waterproofing chemical as well as its solid, consistent property, in addition to the ability to comply with each setup is making its need increase in the worldwide construction industry. Utilization of terrible value construction material
Liquid Milk Market In 2017, the global Liquid Milk market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Liquid Milk market based on company, product type, application and key regions. This report studies the global market size of Liquid Milk in key regions like North America, Europe, Asia
Liquid Productions announces name change
13 years since it’s foundation, top creative content production agency Liquid Productions is evolving, with a new name to match a new vision. As of the 10th October the new name for the business is LIQUONA. Repeatedly ranked by industry magazine Televisual as a Top 50 UK corporate production company, LIQUONA has grown from a bedroom startup video production company, to a full creative moving image agency. The name change reflects the development of
Liquid Biopsy Market - Insights
Liquid biopsy involves testing of the blood to identify biomarkers or cancer cells in the form of cells or pieces of DNA which are separated from the tumor and are circulating in the blood. Liquid biopsy helps in early detection of cancer, which would aid in adopting an optimal treatment plan. It is a non-invasive technique, which makes frequent testing possible, and effectiveness of cancer treatment can also be validated
Global Liquid Nitrogen Market 2017
Global Liquid Nitrogen Report 2017 Major Manufacture Analysis Of Liquid Nitrogen Market 2017. The report presents a Depth Research of the market growth factors and drivers. A Deep research of the Liquid Nitrogen Market limitations and the opportunities enable the user to make the future projection. The report also includes Company Profile, based on the manufacturing methods, technological advancements, and innovations. GET SAMPLE REPORT @ The report has been prepared based